
Merck Sharp & Dohme (MSD) reduced validation time by 50%
MSD digitized seven validation processes globally, reducing cycle times by 50%, process steps by 46%, and replacing three QMS systems.
Resources

55% call GxP AI high risk. 78% expect it standard by 2030. See the global data set.

Get a playbook to build the business case, quantify value and secure investment for digital validation at your organization.

Get a five-pillar framework for implementing AI in this ISPE best practices webinar.
60 Min
Amy Wilhite, David Corley

Pharma leaders reveal how to harmonize digital validation with Kneat Gx across sites.
Leslie Lighton-Humphreys, Sarah Grogan, Vasilios Tsatsaias

Kneat Gx 26R2 offers even more time-saving features with deeper compliance.

Get a data-driven roadmap for your medical device validation strategy in 2026 and beyond.

Get Kneat's step-by-step checklist for planning and executing a validation platform transition.

A practical guide to analytical method validation under ICH Q2(R2) — and how to get it right.

See how ISPE and Kneat turn documented bottlenecks into a business case for digital validation.